Addendum. 2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2021</i>. Diabetes Care 2021;44(Suppl. 1):S15–S33
E Sims, B Bundy, K Stier, K Herold, B Bundy, S Long
Abstract
Section 2, Classification and Diagnosis of Diabetes, of the Standards of Medical Care in Diabetes-2021 has been annotated to include evidence from a trial on anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes that was reported in 2019, with an extension of the trial reported in 2021.
Topics & Concepts
MedicineDiabetes mellitusAddendumFamily medicineIntensive care medicineInternal medicineEndocrinologyPolitical scienceLawDiabetes Management and ResearchDiabetes and associated disordersHyperglycemia and glycemic control in critically ill and hospitalized patients